163 related articles for article (PubMed ID: 31898539)
1. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.
Akizuki K; Sekine M; Kogure Y; Kameda T; Shide K; Koya J; Kamiunten A; Kubuki Y; Tahira Y; Hidaka T; Kiwaki T; Tanaka H; Sato Y; Kataoka H; Kataoka K; Shimoda K
BMC Cancer; 2020 Jan; 20(1):5. PubMed ID: 31898539
[TBL] [Abstract][Full Text] [Related]
2. Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.
Oshrine BR; Olsen MN; Heneghan M; Wertheim G; Daber R; Wilmoth DM; Biegel JA; Pawel B; Aplenc R; King RL
Cancer Genet; 2014 Apr; 207(4):153-9. PubMed ID: 24831771
[TBL] [Abstract][Full Text] [Related]
3. A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.
Lu C; Riedell P; Miller CA; Hagemann IS; Westervelt P; Ozenberger BA; O'Laughlin M; Magrini V; Demeter RT; Duncavage EJ; Griffith M; Griffith OL; Wartman LD
Cold Spring Harb Mol Case Stud; 2016 Jan; 2(1):a000687. PubMed ID: 27148581
[TBL] [Abstract][Full Text] [Related]
4. Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics.
Amra N; Zarate LV; Punia JN; Mahajan P; Stevens AM; Roy A; Curry CV; Cortes-Santiago N; Fisher KE
Pediatr Dev Pathol; 2020; 23(6):461-466. PubMed ID: 32815783
[TBL] [Abstract][Full Text] [Related]
5. Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.
Yu N; Kim HR; Cha YJ; Park EK; Kim JW
J Korean Med Sci; 2011 Aug; 26(8):1099-102. PubMed ID: 21860563
[TBL] [Abstract][Full Text] [Related]
6. Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia.
Tang KHK; Ip AHW; Kwong YL
Ann Hematol; 2021 May; 100(5):1337-1339. PubMed ID: 33760949
[No Abstract] [Full Text] [Related]
7. Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia.
Mukherjee S; Ibrahimi S; John S; Adnan MM; Scordino T; Khalil MO; Cherry M
Ann Hematol; 2017 Sep; 96(9):1435-1439. PubMed ID: 28578457
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors.
Orazi A; Neiman RS; Ulbright TM; Heerema NA; John K; Nichols CR
Cancer; 1993 Jun; 71(12):3873-81. PubMed ID: 8389653
[TBL] [Abstract][Full Text] [Related]
9. Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.
Leonard JT; Raess PW; Dunlap J; Hayes-Lattin B; Tyner JW; Traer E
J Hematol Oncol; 2016 Mar; 9():31. PubMed ID: 27036514
[TBL] [Abstract][Full Text] [Related]
10. The Role of
Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
[TBL] [Abstract][Full Text] [Related]
11. TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Bacon JVW; Giannatempo P; Cataldo G; Fazli L; Saxena N; Ozgun G; Soleimani M; Chi K; Nichols C; Necchi A; Wyatt AW; Kollmannsberger CK; Nappi L
Oncologist; 2022 Nov; 27(11):e912-e915. PubMed ID: 36166584
[TBL] [Abstract][Full Text] [Related]
12. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
[TBL] [Abstract][Full Text] [Related]
13. The genetic landscape of 87 ovarian germ cell tumors.
Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
[TBL] [Abstract][Full Text] [Related]
15. Detection and Correlation of Single and Concomitant
Pessôa IA; Amorim CK; Ferreira WAS; Sagica F; Brito JR; Othman M; Meyer B; Liehr T; de Oliveira EHC
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151164
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis.
Gao L; Hong X; Guo X; Cao D; Gao X; DeLaney TF; Gong X; Chen R; Ni J; Yao Y; Wang R; Chen X; Tian P; Xing B
Oncotarget; 2016 Jul; 7(28):43557-43569. PubMed ID: 27248819
[TBL] [Abstract][Full Text] [Related]
17. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Welch JS; Petti AA; Miller CA; Fronick CC; O'Laughlin M; Fulton RS; Wilson RK; Baty JD; Duncavage EJ; Tandon B; Lee YS; Wartman LD; Uy GL; Ghobadi A; Tomasson MH; Pusic I; Romee R; Fehniger TA; Stockerl-Goldstein KE; Vij R; Oh ST; Abboud CN; Cashen AF; Schroeder MA; Jacoby MA; Heath SE; Luber K; Janke MR; Hantel A; Khan N; Sukhanova MJ; Knoebel RW; Stock W; Graubert TA; Walter MJ; Westervelt P; Link DC; DiPersio JF; Ley TJ
N Engl J Med; 2016 Nov; 375(21):2023-2036. PubMed ID: 27959731
[TBL] [Abstract][Full Text] [Related]
18. Hematologic neoplasia associated with primary mediastinal germ-cell tumors.
Nichols CR; Roth BJ; Heerema N; Griep J; Tricot G
N Engl J Med; 1990 May; 322(20):1425-9. PubMed ID: 2158625
[TBL] [Abstract][Full Text] [Related]
19. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
